Streptococcus intermedius : an underestimated pathogen in brain infection?

Autor: Gil E; UCL Respiratory, Division of Medicine, University College London, London, WC1E 6JF, UK.; Clinical Research Department, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK.; Division of Infection, University College London Hospital, London, NW1 2BU, UK.; Department of Microbiology, Virology & Infection Control, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, WC1N 1EH, UK., Hatcher J; Department of Microbiology, Virology & Infection Control, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, WC1N 1EH, UK.; Department of Infection, Immunity & Inflammation, UCL Great Ormond Street Institute of Child Health, London, WC1N 1EH, UK., Saram S; Division of Infection, University College London Hospital, London, NW1 2BU, UK., Guy RL; Healthcare-Associated Infection & Antimicrobial Resistance Division, UK Health Security Agency, London, NW9 5EQ, United Kingdom., Lamagni T; Healthcare-Associated Infection & Antimicrobial Resistance Division, UK Health Security Agency, London, NW9 5EQ, United Kingdom., Brown JS; UCL Respiratory, Division of Medicine, University College London, London, WC1E 6JF, UK.

Publikováno v: Future microbiology [Future Microbiol] 2024 Nov 18, pp. 1-15. Date of Electronic Publication: 2024 Nov 18.

Predicting future hospital antimicrobial resistance prevalence using machine learning.

Autor: Vihta KD; Modernising Medical Microbiology, Experimental Medicine, Nuffield Department of Medicine, Level 7 Research Offices, John Radcliffe Hospital, Headley Way, University of Oxford, Oxford, UK. karina.vihta@gmail.com.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK. karina.vihta@gmail.com.; Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, UK. karina.vihta@gmail.com., Pritchard E; Modernising Medical Microbiology, Experimental Medicine, Nuffield Department of Medicine, Level 7 Research Offices, John Radcliffe Hospital, Headley Way, University of Oxford, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK., Pouwels KB; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK.; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Hopkins S; Healthcare-associated infections, Fungal, Antimicrobial resistance, Antimicrobial usage, & Sepsis Division, UK Health Security Agency, London, UK., Guy RL; Healthcare-associated infections, Fungal, Antimicrobial resistance, Antimicrobial usage, & Sepsis Division, UK Health Security Agency, London, UK., Henderson K; Healthcare-associated infections, Fungal, Antimicrobial resistance, Antimicrobial usage, & Sepsis Division, UK Health Security Agency, London, UK., Chudasama D; Healthcare-associated infections, Fungal, Antimicrobial resistance, Antimicrobial usage, & Sepsis Division, UK Health Security Agency, London, UK., Hope R; Healthcare-associated infections, Fungal, Antimicrobial resistance, Antimicrobial usage, & Sepsis Division, UK Health Security Agency, London, UK., Muller-Pebody B; Healthcare-associated infections, Fungal, Antimicrobial resistance, Antimicrobial usage, & Sepsis Division, UK Health Security Agency, London, UK., Walker AS; Modernising Medical Microbiology, Experimental Medicine, Nuffield Department of Medicine, Level 7 Research Offices, John Radcliffe Hospital, Headley Way, University of Oxford, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK.; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Clifton D; Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, UK.; OSCAR (Oxford Suzhou Centre for Advanced Research), University of Oxford, Suzhou, China., Eyre DW; Modernising Medical Microbiology, Experimental Medicine, Nuffield Department of Medicine, Level 7 Research Offices, John Radcliffe Hospital, Headley Way, University of Oxford, Oxford, UK.; The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK.; The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.; Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.

Publikováno v: Communications medicine [Commun Med (Lond)] 2024 Oct 10; Vol. 4 (1), pp. 197. Date of Electronic Publication: 2024 Oct 10.

Rapid expansion and international spread of M1 UK in the post-pandemic UK upsurge of Streptococcus pyogenes.

Autor: Vieira A; Department of Infectious Disease, Imperial College London, London, UK.; Centre for Bacterial Resistance Biology, Imperial College London, London, UK.; NIHR Health Protection Research Unit in Healthcare-associated Infections and AMR, Imperial College London, London, UK., Wan Y; Department of Infectious Disease, Imperial College London, London, UK.; NIHR Health Protection Research Unit in Healthcare-associated Infections and AMR, Imperial College London, London, UK.; Healthcare-Associated Infections, Fungal, AMR, AMU, and Sepsis Division, UK Health Security Agency, London, UK., Ryan Y; Reference Services Division, UK Health Security Agency, London, UK., Li HK; Department of Infectious Disease, Imperial College London, London, UK.; Centre for Bacterial Resistance Biology, Imperial College London, London, UK., Guy RL; Healthcare-Associated Infections, Fungal, AMR, AMU, and Sepsis Division, UK Health Security Agency, London, UK., Papangeli M; Department of Infectious Disease, Imperial College London, London, UK.; Centre for Bacterial Resistance Biology, Imperial College London, London, UK., Huse KK; Department of Infectious Disease, Imperial College London, London, UK.; Centre for Bacterial Resistance Biology, Imperial College London, London, UK., Reeves LC; Department of Infectious Disease, Imperial College London, London, UK.; Centre for Bacterial Resistance Biology, Imperial College London, London, UK., Soo VWC; Department of Infectious Disease, Imperial College London, London, UK.; Centre for Bacterial Resistance Biology, Imperial College London, London, UK., Daniel R; Reference Services Division, UK Health Security Agency, London, UK., Harley A; Reference Services Division, UK Health Security Agency, London, UK., Broughton K; Reference Services Division, UK Health Security Agency, London, UK., Dhami C; Reference Services Division, UK Health Security Agency, London, UK., Ganner M; Reference Services Division, UK Health Security Agency, London, UK., Ganner MA; Reference Services Division, UK Health Security Agency, London, UK., Mumin Z; Reference Services Division, UK Health Security Agency, London, UK., Razaei M; Reference Services Division, UK Health Security Agency, London, UK., Rundberg E; Reference Services Division, UK Health Security Agency, London, UK., Mammadov R; Reference Services Division, UK Health Security Agency, London, UK., Mills EA; Department of Infectious Disease, Imperial College London, London, UK.; Centre for Bacterial Resistance Biology, Imperial College London, London, UK., Sgro V; Department of Infectious Disease, Imperial College London, London, UK., Mok KY; Department of Infectious Disease, Imperial College London, London, UK., Didelot X; School of Life Sciences and Department of Statistics, University of Warwick, Coventry, UK., Croucher NJ; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK., Jauneikaite E; NIHR Health Protection Research Unit in Healthcare-associated Infections and AMR, Imperial College London, London, UK.; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK., Lamagni T; NIHR Health Protection Research Unit in Healthcare-associated Infections and AMR, Imperial College London, London, UK.; Healthcare-Associated Infections, Fungal, AMR, AMU, and Sepsis Division, UK Health Security Agency, London, UK., Brown CS; NIHR Health Protection Research Unit in Healthcare-associated Infections and AMR, Imperial College London, London, UK.; Healthcare-Associated Infections, Fungal, AMR, AMU, and Sepsis Division, UK Health Security Agency, London, UK., Coelho J; NIHR Health Protection Research Unit in Healthcare-associated Infections and AMR, Imperial College London, London, UK. Juliana.coelho@ukhsa.gov.uk.; Healthcare-Associated Infections, Fungal, AMR, AMU, and Sepsis Division, UK Health Security Agency, London, UK. Juliana.coelho@ukhsa.gov.uk.; Reference Services Division, UK Health Security Agency, London, UK. Juliana.coelho@ukhsa.gov.uk., Sriskandan S; Department of Infectious Disease, Imperial College London, London, UK. s.sriskandan@imperial.ac.uk.; Centre for Bacterial Resistance Biology, Imperial College London, London, UK. s.sriskandan@imperial.ac.uk.; NIHR Health Protection Research Unit in Healthcare-associated Infections and AMR, Imperial College London, London, UK. s.sriskandan@imperial.ac.uk.

Publikováno v: Nature communications [Nat Commun] 2024 May 10; Vol. 15 (1), pp. 3916. Date of Electronic Publication: 2024 May 10.

The laboratory investigation, management, and infection prevention and control of Candida auris : a narrative review to inform the 2024 national guidance update in England.

Autor: Jones CR; HCAI, Fungal, AMR, AMU, and Sepsis Division, UK Health Security Agency, London, UK., Neill C; HCAI, Fungal, AMR, AMU, and Sepsis Division, UK Health Security Agency, London, UK., Borman AM; UKHSA Mycology Reference Laboratory, National Infection Services, UKHSA South West Laboratory, Science Quarter, Southmead Hospital, Bristol, UK.; MRC Centre for Medical Mycology, University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter, UK., Budd EL; HCAI, Fungal, AMR, AMU, and Sepsis Division, UK Health Security Agency, London, UK., Cummins M; Department of Microbiology and Infection Control, Barts Health NHS Trust, London, UK., Fry C; HCAI, Fungal, AMR, AMU, and Sepsis Division, UK Health Security Agency, London, UK., Guy RL; HCAI, Fungal, AMR, AMU, and Sepsis Division, UK Health Security Agency, London, UK., Jeffery K; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Johnson EM; UKHSA Mycology Reference Laboratory, National Infection Services, UKHSA South West Laboratory, Science Quarter, Southmead Hospital, Bristol, UK.; MRC Centre for Medical Mycology, University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter, UK., Manuel R; Public Health Laboratory London, Science Group, UK Health Security Agency, London, UK., Mirfenderesky M; HCAI, Fungal, AMR, AMU, and Sepsis Division, UK Health Security Agency, London, UK., Moore G; Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury, UK., Patel B; Public Health Laboratory London, Science Group, UK Health Security Agency, London, UK., Schelenz S; Department of Microbiology, King's College Hospital NHS Foundation Trust, London, UK., Staniforth K; HCAI, Fungal, AMR, AMU, and Sepsis Division, UK Health Security Agency, London, UK., Taori SK; Department of Medical Microbiology, NHS Lothian, Edinburgh, UK., Brown CS; HCAI, Fungal, AMR, AMU, and Sepsis Division, UK Health Security Agency, London, UK.; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.

Publikováno v: Journal of medical microbiology [J Med Microbiol] 2024 May; Vol. 73 (5).

Nitrofurantoin resistance as an indicator for multidrug resistance: an assessment of Escherichia coli urinary tract specimens in England, 2015-19.

Autor: Guy RL; Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA), Colindale, London, UK., Rudman J; Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA), Colindale, London, UK., Higgins H; Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA), Colindale, London, UK., Carter E; Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA), Colindale, London, UK., Henderson KL; Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA), Colindale, London, UK., Demirjian A; Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA), Colindale, London, UK.; Department of Paediatric Infectious Diseases & Immunology, Evelina London Children's Hospital, London, SE1 7EH, UK.; Faculty of Life Sciences & Medicine, King's College London, London, UK., Gerver SM; Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA), Colindale, London, UK.

Publikováno v: JAC-antimicrobial resistance [JAC Antimicrob Resist] 2023 Nov 17; Vol. 5 (6), pp. dlad122. Date of Electronic Publication: 2023 Nov 17 (Print Publication: 2023).